Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
There is a takeover in the medium term coming, so hold on and wait and see.
I was right before and I am right now.............wait for it.
Needs a big buyer to come in and make a difference here.
Hillary Clinton has pro-medical marijuana voters locked in
http://www.businessinsider.com/hillary-clinton-medical-marijuana-voters-presidential-election-2016-10
Legalized Marijuana In Canada Would Be Worth Up To $22.6B Per Year
http://www.huffingtonpost.ca/2016/10/27/marijuana-legalization-market-size-canada_n_12676754.html
ABATTIS BIOCEUTICALS CORP
ATT:CANADIAN SECURITIES EXCHANGEView ATTBF on the OTCQB
Set Alert
Add to WatchList
Last Change Bid (size) Ask (size) Volume Day Range
$0.180
-$0.01
(-5.26%)
0.165 (158) 0.180 (562) 3,000,727 0.160 - 0.190
Similar but slower pattern to 2014, a few days in the red and then a few days in the green.
As I said yesterday and today in the red and low % gains for the rest of the week maybe a little red day on Friday as people get bored and pick up some profit.
should be a drop in the pps today and tomorrow, the PR earlier put it up a bit but its not sustainable. Then should continue to increase the rest of the week.
Rumour on new CEO coming in was also proved right.
well there is the buy out that one of the rumours advised would happen which I advised I had heard last week.
most Canadian Marijuana stocks will increase after Nov 8th. ATT is so much more then just a testing facility. They are also involved in using marijuana for pain caused by inflammation and mental ailments... I see this being a big industry in the future!
Go to their website http://www.abattis.com/companies and scroll to the bottom to see all the companies make up ATT.
Read more at http://www.stockhouse.com/companies/bullboard/attbf/abattis-bioceuticals-corp#WqMbE2Pe6lzpu6W0.99
!!!!! BREAKING NEWS ATT AIMS US MARKET !!!!
http://www.bestmedicalmarijuanastocks.com/abattis-bioceuticals/
Read more at http://www.stockhouse.com/companies/bullboard/attbf/abattis-bioceuticals-corp#SGMoPpkZbDvTbPEP.99
Abattis Information to Be Available in S&P Capital IQ Market Access Program
VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 25, 2015) - Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTCQX:ATTBF)(CSE:ATT), a specialty biotechnology company with capabilities through its wholly-owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds and patented equipment to medicinal markets in North America, would like to announced today that its company information will be made available via S&P Capital IQ's Market Access Program, an information distribution service that enables subscribing publicly traded companies to have their company information disseminated to users of S&P Capital IQ's MarketScope Advisor. The company information to be made available through this program includes share price, volume, dividends, shares outstanding, company financial position, and earnings. MarketScope Advisor is an Internet-based research engine used by more than 100,000 investment advisors. A public version of the site is available at http://advisor.marketscope.com.
In addition, information about companies in S&P Capital IQ's Market Access Program will be available via the firm's Stock Guide database, which is distributed electronically to virtually all major quote vendors. As part of the program, a full description of Abattis Bioceuticals Corp. will also be published in the Daily News section of Standard & Poor's Corporation Records, a recognized securities manual for secondary trading in up to 38 states under their Blue Sky Laws.
About Abattis Bioceuticals Corp.
Abattis is a specialty biotechnology company with capabilities through its wholly-owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America. The Company is positioned to capitalize on the fast growing trend toward marijuana legalization in the United States and for medicinal use in Canada and international jurisdictions, by supplying and partnering with companies to employ its mass cultivation systems, extraction equipment/technology, and strategic marketing support to licensed growers. The Company also has an extensive pipeline of high-quality products and intellectual property for the rapidly expanding botanical drug market. We follow strict standard operating protocols, and adhere to the applicable laws of Canada and foreign jurisdictions. For more information, visit the Company's website at: www.abattis.com.
About S&P Capital IQ
S&P Capital IQ, a part of McGraw Hill Financial (NYSE:MHFI), is a leading provider of multi-asset class and real time data, research and analytics to institutional investors, investment and commercial banks, investment advisors and wealth managers, corporations and universities around the world. S&P Capital IQ provides a broad suite of capabilities designed to help track performance, generate alpha, and identify new trading and investment ideas, and perform risk analysis and mitigation strategies. Through leading desktop solutions such as the S&P Capital IQ, Global Credit Portal and MarketScope Advisor desktops; enterprise solutions such as S&P Capital IQ Valuations; and research offerings, including Leveraged Commentary & Data, Global Markets Intelligence, and company and funds research, S&P Capital IQ sharpens financial intelligence into the wisdom today's investors need. For more information, visit www.spcapitaliq.com.
The stock price direction for the day for ATTBF is UP. The stock is experiencing a strong uptrend as of late, with an increase of more than 15 percent in the last five days. Based on BullishInvestor.com’s proprietary algorithms, ATTBF is currently signalling BULLISH.
The most recent Candle Stick pattern for ATTBF is the Belt-hold. Overall the technical indicators are signaling a bullish reading for ATTBF. As such, it may be a wise decision to consider ATTBF at these price levels. The last BEARISH rating was registered on Sep 15, 2016 when ATTBF was trading at $ 0.03.
This stock now finds itself with a new BULLISH rating and is worthy of a new look from a technical analysis perspective.
SEATTLE, WA -- (Marketwired) -- 10/18/16 -- CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article covering Canada's new cannabis testing regulations and why Abattis Bioceuticals' (OTCQB: ATTBF) Northern Vine Labs is well positioned in this burgeoning market.
In July 2016 the Globe and Mail conducted an investigation into contamination in cannabis after purchasing products from nine storefronts in Toronto. Their research team found that one-third of the samples would not pass a Health Canada safety test. Three of the nine samples contained excessively high levels of bacteria and one not only contained mold but yeast at concentrations that could cause serious lung conditions.
Surprisingly, the Controlled Drugs and Substances Act prevented government-approved cannabis testing facilities from possessing any amount of the drug brought in by the public. With hundreds of illegal dispensaries operating outside of the MMPR program, this meant that consumers had no way of knowing if their product was safe. Consequently, in August 2016, Health Canada introduced an exemption to the Controlled Drugs and Substances Act that allowed government-approved labs to test any cannabis products.
Abattis Bioceuticals' Northern Vine Labs recently secured a Controlled Substance License with Health Canada for the possession of cannabis and related active ingredients, as well as the production of extracts for the purpose of analysis. The company offers cutting-edge cannabis testing and research services to licensed producers, law enforcement and other CSLs.
Northern Vine's long-term goal is to become a partner in both cannabis testing and product development. By building up its expertise in extracts, the company is positioned to take advantage of the industry's transition from dried cannabis to more conventional delivery methods like functional foods and capsules. While the independent nature of the lab results will reassure medical professionals and patients, licensed producers would benefit from the cost-savings of outsourcing these activities.
Click here to read the full article: http://www.cannabisfn.com/abattis-attbf-a-leader-in-canadas-cannabis-testing-industry/
The rise in pps was a bit higher than is good for the short term indicators.
Hence probably a couple of days in the start of next week of in the red while some profits are taken.
Things to watch are short levels, shares on offer in the higher teens and 20's moving forward, chart resistance levels of 20c for ATTBF and 25c for ATT.
Of course any PR will have to be substantive as well as any news on the sector in general, like any California polls indicating where the voters are for the legalization vote.
Any fluff PR's could do more damage in the downward pps direction, as too many have been pumped out previously in this sector.
Chart looks good for a ride though.
End of the session::
ABATTIS BIOCEUTICALS CORP
ATT:CANADIAN SECURITIES EXCHANGEView ATTBF on the OTCQB
Set Alert
Add to WatchList
Last Change Bid (size) Ask (size) Volume Day Range
$0.225
+$0.035
(18.42%)
0.210 (129) 0.225 (66) 1,983,018 0.175 - 0.230
Yes the charts look similar to 2014 but people were bitten then and so need to expect caution this time and a slower rise.
Still doing ok and the GS report will help a lot saying 30c and beyond.
The charts were right in 2014 so can hope they are this time.
Need a level to jump out though as its high risk I jumped out at 76c last time and still did very well.
Up 7% at the moment which is better and we may see stability or a few more % in the next 2 hours to close.
The pattern is developing as per 2014 run to the peak, a bit slower this time maybe due to caution, but the GS recommendation could be filtering through.
The offer at ATT is now 21c and there is not many being offered until 23c right now could change as people take some profit.
Volume on ATTBF is lower so its slower but is crawling back up as I thought it would.
Only 3000 shares offered until 21c in ATT then 176,000 at 21c.
As I said two days in red then small climb up.
ATT just hit 20c
ABATTIS BIOCEUTICALS CORP
ATT:CANADIAN SECURITIES EXCHANGEView ATTBF on the OTCQB
Set Alert
Add to WatchList
Last Change Bid (size) Ask (size) Volume Day Range
$0.200
+$0.010
(5.26%)
0.195 (18) 0.200 (15) 1,251,628 0.175 - 0.200
I 'heard' that at 75c a BIG announcement is to be made, rumour of course but one never knows with this.
ABATTIS BIOCEUTICALS CORP
ATT:CANADIAN SECURITIES EXCHANGEView ATTBF on the OTCQB
Set Alert
Add to WatchList
Last Change Bid (size) Ask (size) Volume Day Range
$0.195
+$0.005
(2.63%)
0.190 (18) 0.195 (53) 1,094,528 0.175 - 0.195
ATT which just went green at 19.5c
Canadian side is back to 19c level where it started on open.
The GS speculative buy recommendation should filter through soon and start things off but they need a genuine PR to do a good lift to 75c.
Abattis’ NVL subsidiary awarded coveted Controlled Substance License. Northern Vine Labs (NVL) is one of the few 3rd party analytical testing labs for Cannabis in British Columbia and 1 of only 18 in all of Canada. As the lab is built out and services launched in the coming months, ATTBF is primed to enjoy meaningful revenue from the testing of potency, microbial and others.
The climb back is going to start soon and should end up in the green slightly today.
ABATTIS BIOCEUTICALS CORP
ATT:CANADIAN SECURITIES EXCHANGEView ATTBF on the OTCQB
Set Alert
Add to WatchList
Last Change Bid (size) Ask (size) Volume Day Range
$0.190
-$0.02
(-9.52%)
0.185 (38) 0.190 (388) 2,547,510 0.170 - 0.225
Here is the currently Canadian side chart right now::
http://ih.advfn.com/p.php?pid=charts&symbol=CNSX%5EATT&period=1&freq=0
Here is the Canadian side level two right now::
# Orders Shares Bid Ask Shares # Orders
3 26500 0.185 0.190 30000 1
7 50500 0.180 0.195 184000 5
5 327000 0.175 0.200 20500 3
12 148000 0.170 0.210 41500 3
4 12500 0.165 0.220 108000 2
Volume on the US side needs to increase, the Canadian side is doing well at 2.5million.
Should move up in the last 2 hours of today according to the chart I looked at, not sure if it will go into green. Maybe tomorrow will show a 5% increase.
Abattis (ATTBF): A Leader in Canada's Cannabis Testing Industry -- CFN Media
MKTW
Abattis (ATTBF): A Leader in Canada's Cannabis Testing Industry -- CFN Media
SEATTLE, WA--(Marketwired - Oct 18, 2016) - CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article covering Canada's new cannabis testing regulations and why Abattis Bioceuticals' (OTCQB: ATTBF) Northern Vine Labs is well positioned in this burgeoning market.
In July 2016 the Globe and Mail conducted an investigation into contamination in cannabis after purchasing products from nine storefronts in Toronto. Their research team found that one-third of the samples would not pass a Health Canada safety test. Three of the nine samples contained excessively high levels of bacteria and one not only contained mold but yeast at concentrations that could cause serious lung conditions.
Surprisingly, the Controlled Drugs and Substances Act prevented government-approved cannabis testing facilities from possessing any amount of the drug brought in by the public. With hundreds of illegal dispensaries operating outside of the MMPR program, this meant that consumers had no way of knowing if their product was safe. Consequently, in August 2016, Health Canada introduced an exemption to the Controlled Drugs and Substances Act that allowed government-approved labs to test any cannabis products.
Abattis Bioceuticals' Northern Vine Labs recently secured a Controlled Substance License with Health Canada for the possession of cannabis and related active ingredients, as well as the production of extracts for the purpose of analysis. The company offers cutting-edge cannabis testing and research services to licensed producers, law enforcement and other CSLs.
Northern Vine's long-term goal is to become a partner in both cannabis testing and product development. By building up its expertise in extracts, the company is positioned to take advantage of the industry's transition from dried cannabis to more conventional delivery methods like functional foods and capsules. While the independent nature of the lab results will reassure medical professionals and patients, licensed producers would benefit from the cost-savings of outsourcing these activities.
Democratic presidential nominee Hillary Clinton supports decriminalizing marijuana in principle but isn’t yet sold on the details of how to implement the policy change, a newly leaked transcript of a meeting with Black Lives Matter (BLM) activists shows.
“From my perspective we do need to look hard at decriminalizing behavior that is not harmful, that is not leading to violence, and try to figure out how best to do that,” Clinton said in response to a BLM organizer’s question about removing criminal penalties for cannabis and sex work, which have “historically been used to oppress” communities of color.
“I support the idea of it,” Clinton said. “I’m not sure exactly how you would implement it and how — you know, because remember, most of the laws you’re talking about are state and local laws. I mean, the federal government can encourage, can make suggestions, can provide incentives, but most criminal law, most policing, all of the problems that we’ve been discussing are really controlled at the local and the state level. So you have to have a buy-in by others, not just by the federal government.”
The transcript, attached to an email from the hacked account of John Podesta, the Clinton campaign’s chairman, was published on Friday by WikiLeaks.
“I think there is more conversation going on about this now, at least that I am aware of, of people talking about what can be done to decriminalize low-level offenses to try to avoid prison, to try to provide different kinds of support and diversionary measures to people who might be in need,” Clinton said in the meeting with BLM activists, which took place on October 9 of last year.
The Prime Minister of Canada has made steps forward by announcing a task force to gather research, setting up a portal to hear Canadians thoughts on the issue, and even amending the old law so MMJ patients can grow their own. This has not stopped critics from condemning his silence on how it all may be executed in the Spring of 2017.
Because the federal government is clearly not talking, the only way to speculate on what might happen would be to look at the polls that tell us what Canadians want out of their legalized cannabis industry.
A recent poll was done by the Canadian research company Insights West, who surveyed 1,033 Canadians about marijuana. At the very least, the poll shows that Canadians approve of Trudeau legalizing, as sixty-two percent said they supported the legislation.
Not surprisingly, the people surveyed who had tried marijuana or who smoke it regularly were ninety-four percent in favour of legalization in some form. Eighteen percent want decriminalization of pot and nothing more.
Look at the chart compared to the 2014 run, its on target to repeat the rise it had previously.
Went down as predicted, maybe same drop tomorrow, chart will firm up then for next leg up to 75c.